SEC Form 4 · accession 0001193125-26-385511
AN2 Therapeutics, Inc. · ANTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin Shane Readnour
Director
Period of report
Sep 3, 2026
Accepted (ET)
Sep 8, 2026 · 7:42 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001880438
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF3,F4,F5 | Sep 3, 2026 | S | 2,877 | $6.0698 | D | 562,715 | I | See footnotes |
| Common StockF3,F4,F6 | Sep 3, 2026 | S | 3,223 | $6.0698 | D | 630,644 | I | See footnotes |
| Common StockF3,F4,F5 | Sep 8, 2026 | S | 4,725 | $6.0183 | D | 557,990 | I | See footnotes |
| Common StockF3,F4,F6 | Sep 8, 2026 | S | 5,294 | $6.0183 | D | 625,350 | I | See footnotes |
| Common Stock | holding | — | — | — | 9,077 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by MGC Venture Partners 2018, LP ("MGC 2018 LP") on April 23, 2026.
- F2The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by MGC Venture Partners QP 2018, LP ("MGC 2018 QP") on April 23, 2026.
- F3Represents the weighted average sale price for multiple transactions ranging from $6.000 to $6.085, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the price range reported herein.
- F4MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP. MGC 2018 GP has shared voting and shared dispositive power over the shares held by MGC 2018 LP and MGC 2018 QP. The Reporting Person is a member of the Issuer's board of directors and is a member of MGC 2018 QP and MGC 2018 LP and a managing partner of MGC 2018 GP and has shared voting power and shared dispositive power over the shares of common stock held by MGC 2018 LP and MGC 2018 QP. The Reporting Person disclaims beneficial ownership of the securities, except to the extent of such person's pecuniary interest in such securities.
- F5Shares held directly by MGC 2018 LP.
- F6Shares held directly by MGC 2018 QP.